RT Journal Article
SR Electronic
T1 ABO histo-blood groups influence gut microbiome, with causal relationship between <em>Bacteroides</em> and inflammatory bowel disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.09.20148627
DO 10.1101/2020.07.09.20148627
A1 Malte Christoph Rühlemann
A1 Britt Marie Hermes
A1 Corinna Bang
A1 Shauni Doms
A1 Lucas Moitinho-Silva
A1 Louise Bruun Thingholm
A1 Fabian Frost
A1 Frauke Degenhardt
A1 Michael Wittig
A1 Jan Kässens
A1 Frank Ulrich Weiss
A1 Annette Peters
A1 Klaus Neuhaus
A1 Uwe Völker
A1 Henry Völzke
A1 Georg Homuth
A1 Stefan Weiss
A1 Matthias Laudes
A1 Wolfgang Lieb
A1 Dirk Haller
A1 Markus Maximilian Lerch
A1 John F. Baines
A1 Andre Franke
YR 2020
UL http://medrxiv.org/content/early/2020/07/11/2020.07.09.20148627.abstract
AB The intestinal microbiome is implicated as an important modulating factor in multiple inflammatory,1,2 neurologic,3 and neoplastic diseases.4 Recent genome-wide association studies yielded inconsistent, underpowered and rarely replicated results such that the role of human host genetics as a contributing factor to microbiome assembly and structure remains uncertain.5–11 Nevertheless, twin-studies clearly suggest host-genetics as driver of microbiome composition.11 In a genome-wide association analysis of 8,956 German individuals, we identified 32 genetic loci to be associated with single bacteria and overall microbiome composition. Further analyses confirm the identified associations of ABO histo-blood groups and FUT2 secretor status with Bacteroides and Faecalibacterium. Mendelian randomization analysis suggests causative and protective effects of gut microbes, with clade-specific effects on inflammatory bowel disease. This holistic investigative approach of the host, its genetics, and its associated microbial communities as a ‘metaorganism’ broadens our understanding of disease aetiology and emphasizes the potential for implementing microbiota in disease treatment and management.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center 1182 "Origin and Function of Metaorganisms" (DFG Grant: "SFB1182"; Project A2) and the DFG Cluster of Excellence 2167 "Precision Medicine in Chronic Inflammation (PMI)" (DFG Grant: "EXC2167"). The SHIP part of the study was supported by the PePPP-project (ESF/14-BM-A55_0045/16), and the RESPONSE-project (BMBF grant number 03ZZ0921E). SHIP is part of the Research Network Community Medicine of the University Medicine Greifswald, which is supported by the German Federal State of Mecklenburg-West Pomerania.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Written, informed consent was obtained from all study participants in all cohorts. All protocols were approved by the responsible institutional ethical review committee of Kiel University (PopGen and FoCus cohorts), Technical University of Munich - School of Medicine (KORA cohort) and Greifswald University Hospital (SHIP and SHIP-TREND cohorts) in adherence with the Declaration of Helsinki Principles.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCohort-level summaries of microbial feature abundances are provided in the supplemental matierial. The German mGWAS Browser application is available for local query of results from Dockerhub: https://hub.docker.com/r/mruehlemann/german_mgwas_browser_app. Due to constraints given by the written consent, participant phenotypes, genotyping and 16S rRNA gene sequencing data is available upon request from the respective biobanks: PopGen and Focus: https://portal.popgen.de/ KORA FF4: https://epi.helmholtz-muenchen.de/ SHIP and SHIP-TREND: https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_intro.php https://portal.popgen.de/ https://epi.helmholtz-muenchen.de/ https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_intro.php http://ikmb.shinyapps.io/German_mGWAS_Browser